FIELD: biotechnology.
SUBSTANCE: polypeptide of high-mobility group protein B1 (hereinafter – HMGB1) is proposed, while in the specified HMGB1 polypeptide, at least one, preferably two, more preferably three, most preferably all four tyrosine residues are substituted with an amino acid residue. In the present invention, polynucleotide encoding polypeptide according to the present invention, a vector containing the specified polynucleotide, and a host cell containing the specified polypeptide, the specified polynucleotide and/or the specified vector are also proposed. In addition, within the present invention, methods, kits, and applications related to the specified inventions are also proposed.
EFFECT: group of inventions allows for obtaining HMGB1 polypeptide, the use of which causes increased death of cancer cells.
37 cl, 1 dwg, 1 tbl, 2 ex
Title |
Year |
Author |
Number |
COMBINED DRUGS CONTAINING PKM2 AND HMGB1 MODULATORS |
2016 |
|
RU2768186C2 |
CONSTRUCTED CELLS, EXPRESSING MULTIPLE IMMUNOMODULATORS, AND THEREOF APPLICATION |
2009 |
- Bich Robert Patterson
- Rid Tomas D.
|
RU2573912C2 |
VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF |
2011 |
|
RU2612788C2 |
EXPRESSION OF NEW CELL MARKS |
2018 |
- Shakh, Rutul
- Emtejdzh, Piter
- Yarlagadda, Ramya
|
RU2796334C2 |
CONJUGATES AND COMPOSITIONS FOR IMMUNOTHERAPY AND ANTICANCER TREATMENT |
2010 |
- Berraondo Lopes Pedro
- Foravanti Dzhessika
- Medina Echevers Khose
- Melero Bermekho Ignasio Khaver
- Ochoa Neto Mariya Del Karmen
- Palason Garsia Fransisko De Asis
- Bulfone-Paus Silviya
- Dejtman Ervin Khans
|
RU2597989C2 |
BIOLOGICALLY ACTIVATED DRUGS BASED ON CYTOKINES AND METHODS OF USING THEM |
2019 |
- Li Yue-Sheng
- Rui Lingyun
- Xu Jing
|
RU2819307C2 |
TRANSGENIC GENETIC LABELS AND METHODS OF USE |
2015 |
- Dzhensen, Majkl K.
- Dzhonson, Adam
|
RU2822461C1 |
TRANSGENIC GENETIC LABELS AND METHODS OF USING |
2015 |
- Dzhensen Majkl K.
- Dzhonson Adam
|
RU2729112C2 |
METHODS FOR TREATING CANCER, INCLUDING TIGIT-BINDING AGENTS |
2017 |
- Dyupon, Dzhejkob
- Parmar, Khema
|
RU2765410C2 |
ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) |
1998 |
- Georgiev Georgij
- Kiselev Sergej
- Prokhorchuk Egor
- Ostermann Ehlinborg
|
RU2238976C2 |